Literature DB >> 7924483

Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis.

R A Pleasants1, T R Walker, W M Samuelson.   

Abstract

Certain antibiotics, particularly piperacillin, have been reported to be associated with a high incidence of allergic reactions in patients with cystic fibrosis. We initiated a study to determine the relative frequency of allergic reactions, ie, drug-induced fever and rash, to parenteral beta-lactam antibiotics in adult patients with cystic fibrosis. Charts of 111 patients were reviewed for each hospitalization to assess allergic reactions. Of 90 evaluable patients, 26 patients developed one or more allergic reactions to beta-lactam antibiotics. The number of allergic reactions per number of patients receiving specific antibiotics were carbenicillin (4/56), mezlocillin (7/42), piperacillin (11/31), ticarcillin (1/20), cefazolin (0/24), ceftazidime (1/35), imipenem/cilastatin (4/16), and nafcillin (3/36). The mean time to onset of drug-induced fever or of rash was 9.1 days. As a group penicillins had a higher frequency of allergic reactions than cephalosporins. The frequency of reactions was greatest with acylaminopenicillins (mezlocillin and piperacillin) and imipenem/cilastatin. The results of this study indicate that in addition to piperacillin, mezlocillin and imipenem/cilastatin may be associated with a high incidence of allergic reactions in patients with CF.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7924483     DOI: 10.1378/chest.106.4.1124

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy.

Authors:  Lisa M Wheatley; Marshall Plaut; Julie M Schwaninger; Aleena Banerji; Mariana Castells; Fred D Finkelman; Gerald J Gleich; Emma Guttman-Yassky; Simon A K Mallal; Dean J Naisbitt; David A Ostrov; Elizabeth J Phillips; Werner J Pichler; Thomas A E Platts-Mills; Jean-Claude Roujeau; Lawrence B Schwartz; Lauren A Trepanier
Journal:  J Allergy Clin Immunol       Date:  2015-08       Impact factor: 10.793

2.  Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis.

Authors:  Sabah El-Ghaiesh; Manal M Monshi; Paul Whitaker; Rosalind Jenkins; Xiaoli Meng; John Farrell; Ayman Elsheikh; Daniel Peckham; Neil French; Munir Pirmohamed; B Kevin Park; Dean J Naisbitt
Journal:  J Pharmacol Exp Ther       Date:  2012-02-27       Impact factor: 4.030

3.  Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.

Authors:  S Kunzmann; W Thomas; B Mayer; S Kuhn; H Hebestreit
Journal:  Infection       Date:  2010-03-05       Impact factor: 3.553

Review 4.  Antibiotic allergy in cystic fibrosis.

Authors:  J S Parmar; S Nasser
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

Review 5.  The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?

Authors:  D Banerjee; D Stableforth
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

Review 6.  Antibiotic hypersensitivity in patients with CF.

Authors:  Sujatha Ramesh
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

7.  Drug fever induced by piperacillin/tazobactam in an elderly patient with underlying human immunodeficiency virus (HIV) infection.

Authors:  Thein Swe; Mir Ali; Akari Thein Naing
Journal:  BMJ Case Rep       Date:  2016-07-20

8.  Drug Fever: a descriptive cohort study from the French national pharmacovigilance database.

Authors:  Dominique Vodovar; Christine LeBeller; Bruno Mégarbane; Agnes Lillo-Le-Louet; Thomas Hanslik
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

Review 9.  Cystic fibrosis in adults. From researcher to practitioner.

Authors:  G P Marelich; C E Cross
Journal:  West J Med       Date:  1996-04

10.  Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis.

Authors:  Paul Whitaker; Xiaoli Meng; Sidonie N Lavergne; Sabah El-Ghaiesh; Manal Monshi; Caroline Earnshaw; Daniel Peckham; Jimmy Gooi; Steve Conway; Munir Pirmohamed; Rosalind E Jenkins; Dean J Naisbitt; B Kevin Park
Journal:  J Immunol       Date:  2011-05-23       Impact factor: 5.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.